You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb and 360Dx.
Labs like Biodesix, ARUP, Quest, and Labcorp engaged different strategies to prevent loss of patient samples during recent extreme weather.
The firm's over-the-counter claim submission is delayed because it has been unable to find the required number of positive cases among asymptomatic people.
With $1.2 billion in funding earmarked for more than 40 projects, the portfolio represents a path out of the SARS-CoV-2 pandemic for the US.
Executives mapped out the next few years for the firm, estimating a deceleration in COVID-19 testing beginning the second half of 2021.
BD is reinvesting some of its $668 million Veritor Dx windfall into expanding the menu for a newly tripled installed base.
The University of Birmingham-developed method combines a method called EXPAR with a rapid upfront step to obviate reverse transcription.
The firm is also developing an instrument-free molecular diagnostic assay technology for the home testing market.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
The firm plans to begin its OTC efforts with a COVID antigen test but also sees potential in migrating other infectious disease tests.
Some tests that detect multiple SARS-CoV-2 genes are serendipitously signaling new viral variants while still effectively detecting infections.